361 Capital »

Global Blood Therapeutics In shares owned by 361 Capital

Quarter-by-quarter ownership of Global Blood Therapeutics In shares owned by 361 Capital from 13F filings

Historical chart of 361 Capital investment in Global Blood Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Global Blood Therapeutics In held by 361 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global Blood Therapeutics In by 361 Capital

Quarter filed Position value Share count Share price at filing
2020-06-30 $582k 9.2k 63.11

More positions owned by 361 Capital

Schwab International Equity Et Intl Eqty Etf (SCHF)
Schwab U.s. Tips Etf Us Tips Etf (SCHP)
Schwab Emerging Markets Equity Emrg Mkteq Etf (SCHE)
Spdr Blmbg Barclays Inv Grd Fl Blomberg Brc Inv (FLRN)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Schwab U.s. Reit Etf Us Reit Etf (SCHH)
Schwab U.s. Mid Cap Etf Us Mid-cap Etf (SCHM)
Cadence Design Systems (CDNS)
Deckers Outdoor Corporation (DECK)
Berry Plastics (BERY)
Howmet Aerospace (HWM)
Clorox Company (CLX)
Lear Corp Com Cl A (LEA)
AutoZone (AZO)
Dish Network Corp Cl A

View all positions for 361 Capital

Top funds holding Global Blood Therapeutics In

Huntington National Bank

View all funds holding Global Blood Therapeutics In